Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal versus intramuscular naloxone for suspected acute opioid overdose
ACTRN12611000852954Phase 2Completed
- Sponsor
- Sydney Medically Supervised Injecting Centre
- Start
- Jan 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of naloxone in opioid intoxication, sponsored by Sydney Medically Supervised Injecting Centre. Started Jan 2012; status: completed.
02
Drugs
naloxone
03
Conditions
opioid intoxication
Beyond the preview
Go deeper on ACTRN12611000852954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000852954.